Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2004 · 15 citations · 0 references
MedicineBiomedical EngineeringRadiologyBiomedical ImagingCancer ScreeningDiagnostic ImagingBreast AssessmentBreast Cancer ImagingBreast ImagingBreast Lesion CharacterizationMedical ImagingOptical DiagnosticsBreast Tissue ImagingContrastMalignant Breast TumorsNon-invasive ExaminationOptical ContrastTissue Optical DiagnosticsTransparency
Near-infrared (NIR) technology appears promising as a non-invasive clinical technique for breast cancer screening and diagnosis. The technology capitalizes on the relative transparency of human tissue in this spectral range and its sensitivity to the main components of the breast: water, lipid and hemoglobin. In this work we present initial results obtained using the SoftScan® breast-imaging system developed by ART, Advanced Research Technologies inc., Montreal. This platform consists of a 4-wavelength time-resolved scanning system used to quantify non-invasively the local functional state of breast tissue. The different aspects of the system used to accurately retrieve 3D optical contrast will be presented. Furthermore, preliminary data obtained from a prospective study conducted at The Royal Victoria Hospital of the McGill University Health Center in Montreal will be presented. During this study, 65 volunteers with either abnormal or normal mammograms were enrolled. Analysis of the data gathered by SoftScan demonstrated the potential of the technology in discriminating between healthy and diseased tissue.